Could a custom amino acid boost help Parkinson's patients?
NCT ID NCT07115563
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study is testing whether a specially designed amino acid supplement can improve nutrition, reduce oxidative stress, and boost physical and mental health in people with Parkinson's disease. Thirty adults aged 60-80 with Parkinson's will take either the supplement or a placebo daily for six months. Researchers will measure changes in blood amino acids, antioxidant levels, body composition, and overall function.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
targeted amino acid supplement (leucine, tryptophan, arginine, taurine, glutamate, tyrosine)
What this could lead to
If it works, this could point toward a simple nutritional supplement to help manage symptoms and improve quality of life for people with Parkinson's.
What could go wrong
This is a small, early-phase trial with only 30 participants, so results may not apply to everyone. The supplement may not show meaningful benefits over placebo.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PARKINSON DISEASE (PD) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
University of Connecticut
RECRUITINGStorrs, Connecticut, 06269, United States
Contact Email: •••••@•••••
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact